|
| Entrez Id: |
23194 |
| Gene Symbol: |
FBXL7 |
FBXL7
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
1305 |
| Gene Symbol: |
COL13A1 |
COL13A1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
284217 |
| Gene Symbol: |
LAMA1 |
LAMA1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
8091 |
| Gene Symbol: |
HMGA2 |
HMGA2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
22871 |
| Gene Symbol: |
NLGN1 |
NLGN1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
6014 |
| Gene Symbol: |
RIT2 |
RIT2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
10659 |
| Gene Symbol: |
CELF2 |
CELF2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
2104 |
| Gene Symbol: |
ESRRG |
ESRRG
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
9150 |
| Gene Symbol: |
CTDP1 |
CTDP1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
2070 |
| Gene Symbol: |
EYA4 |
EYA4
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
20 |
| Gene Symbol: |
ABCA2 |
ABCA2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
4507 |
| Gene Symbol: |
MTAP |
MTAP
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
30844 |
| Gene Symbol: |
EHD4 |
EHD4
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
27165 |
| Gene Symbol: |
GLS2 |
GLS2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
6768 |
| Gene Symbol: |
ST14 |
ST14
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
55576 |
| Gene Symbol: |
STAB2 |
STAB2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
9420 |
| Gene Symbol: |
CYP7B1 |
CYP7B1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
387890 |
| Gene Symbol: |
TMEM233 |
TMEM233
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
1415 |
| Gene Symbol: |
CRYBB2 |
CRYBB2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
200403 |
| Gene Symbol: |
VWA3B |
VWA3B
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
9580 |
| Gene Symbol: |
SOX13 |
SOX13
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
23236 |
| Gene Symbol: |
PLCB1 |
PLCB1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
9215 |
| Gene Symbol: |
LARGE1 |
LARGE1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
TLCD4-RWDD3
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |
|
| Entrez Id: |
148534 |
| Gene Symbol: |
TLCD4 |
TLCD4
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records.
|
30420678 |
2019 |